We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Scancell Holdings Plc | LSE:SCLP | London | Ordinary Share | GB00B63D3314 | ORD 0.1P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 9.55 | 9.30 | 9.80 | 9.55 | 9.55 | 9.55 | 5,271 | 08:00:00 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
Pharmaceutical Preparations | 5.27M | -11.94M | -0.0129 | -7.40 | 88.61M |
Date | Subject | Author | Discuss |
---|---|---|---|
16/3/2019 17:01 | Hi ONW. Good post as usual. Yes the BOD have stated often enough they need DATA and that will be the proof.They say that they have all interested oarties and big players have a ringside seat. All the need is produce the performance and that imo is within their capabilities. I know I may come across of being critical of the BOD lately but that is essentially centred around a complete lack of any response in the face of a dramatically falling share price and all the attendant risks. Whether they are capable of delivering on a bigger stage I think the jury is still out but I certainly think it is a valid criticism that they do not appear to have taken on the concerns expressed by likes of Panama7 at the AGM and that is what I find most disappointing. ATB | ivyspivey | |
16/3/2019 17:00 | Hi ONW. Good post as usual. Yes the BOD have stated often enough they need DATA and that will be the proof.They say that they have all interested oarties and big players have a ringside seat. All the need is produce the performance and that imo is within their capabilities. I know I may come across of being critical of the BOD lately but that is essentially centred around a complete lack of any response in the face of a dramatically falling share price and all the attendant risks. Whether they are capable of delivering on a bigger stage I think the jury is still out but I certainly think it is a valid criticism that they do not appear to have taken on the concerns expressed by likes of Panama7 at the AGM and that is what I find most disappointing. ATB | ivyspivey | |
16/3/2019 16:02 | Ivy, I think therer's a fundamental problem vis a vis information flow and share price The real problem is IMO that we need Data that underlines and CONFIRMS the science. I'm beginning to think that Scancell has had its honeymoon with the AIM market. It's now moved into the hard facts area (probably about three years ago), and this has really been acknowledged by the BOD when they (collectively) put out the fact that the NECESSITY now is for DATA DATA DATA.. Problem is to get data we need trials, and to get trials we need the NDA (in the first instance) to play ball. We know what the missing part of the jigsaw which we immediately need in that context.... so we have to wait. However, whilst wait the cashburn won't go away... Keeping the lights on (oncluding the (enhanced) salaries, (maybe that was because the Directorial Options - Incentives- weren't paynig off (even after some "judicious" adjustment of the strikes) and as we all know with every month we wait for the IND (the DATA which is the only nourishment for the company's hunger for capital) moves further into the distance and therefore the requirement for more CAPITAL move ever closer. Maybe that's our problem, we don't have what we need to sell the product, we don't have proof... But maybe that's ALWAYS been the case and the IP isn't yet validated so it's only worth 5.5p until the DATA pitches up and that's not GUARANTEED to play ball (even though we hope it does. Have we been looking at all this the wrong way round? Does even Scancell have to prove itself before it gets the accolade share price reflection of the IP value some would suggest, or are we able to claim the value without a full portfolio of industry standard evidence? Are we special or do we hvae to wait in line like evryone else? If not, why not? I reckon we need to establish where the starting point for the company share price wise should have been - oh hang on that would be the adjusted share issuance level, and more importantly where (realistically) we should be now. It's actually quite a sobering process when we consider what hard evidence we can actually show to a potential suitor. I think people need to be quite careeful about all this, because it may actually not totally be the fault of the BOD. Let's try and be REALISTIC about this. AIMO ATB | oldnotwise | |
16/3/2019 14:17 | Ivy - fwiw I agree, communication has been poor, in fact imho it's been abysmal. Attention to detail, such as the Glycan Patent, granted it may not be earth shattering but as a potential source of capital (& in stark relief to no news - good news would stand out) as that's how the Chuckle Bros & Scancell first crossed paths. | gooosed | |
16/3/2019 13:09 | Hi Goosed-it gives back to a conversation I had with RG when he made point with such a small team like SCLP it was important to bring in folk who they knew so not to disrupt it cause friction. I was happy with that at that time with the reservation that it may just get too cosy. Since then my fear has been more realised. Inanaco- don’t want to argue but interested in your views. Are you happy with current share price drop. Are you happy with current communication efforts of SCLP to update Shareholders of progress. Are you happy with BOD efforts in terms of achieving oft stated objectives like actually commencing trials on Combo and Moditope. Put the great science to one side and as others have said a Big White Fluffy Easter Bunny from the hat will have us all very happy. However do you not think the BOD have any responsibility to update SH on progress as it is they both large and small who own the Company. CH is good st responding to individual e mails so why not put the same info in an update so that all SH can have access to their thoughts and insight. This can easily be done without the need for an RNS. It is the absolute silence that I object to.I know many will say that is because they are working on something. We saw from DEs postings about previous discussions under NDA that commercial progress in these matters is often totally heightened by raised expectations rather than reality | ivyspivey | |
16/3/2019 13:03 | Psycho - "I am sure everyone here Loz, is mega impressed .." Maybe BUT, I am sure NO ONE is "mega imoressed" with 5.5p V £8+ . YOU show NO appreciation / understanding of the FACT, that *WE ALL* are 'employed in tackling YOUR *health issues*. Myself, and sooo many others, realise, that by keeping YOUR hands busy/occupied, - YOUR posting 24/7,in response to our 'thoughtful inputs' *WE ALL* are, generously... 'Preventing YOU going blind' *WE ALL*, like YOU, appear to have FAILED | the real lozan | |
16/3/2019 12:31 | Ivy - "Or better in general to have a more dynamic team with different views and perspectives which yes may cause a bit of disruption in a small team but may help overcome a reluctance to make tough decisions to move a business forward." Chiplin has commented that they would look at the NED situation but that they would have to be "careful". Hmmmm - upsetting the apple cart ? In agreement with some others regarding KCB's resignation - clearly her moral compass was functioning perfectly. | gooosed | |
16/3/2019 12:04 | ONW, you're right to bring up remuneration and the Cornish-Bowden issue. Apart from being on the remuneration committee she was also our biggest shareholders voice on the BOD. There is no way their remuneration is justified when you look at the performance of the Company and the lack of any rewards for SH over a six year period and an ever falling share price It is almost back to the initial issue price and when you look at everything the BOD have stated in that time they have failed to deliver anything remotely of substance. | panama7 | |
16/3/2019 12:03 | As sooo many now come to realise...they are { Have been} = ' DONE with INANE'N'CO ' = | the real lozan | |
16/3/2019 11:56 | I am sure everyone here Loz, is mega impressed .. | inanaco | |
16/3/2019 11:50 | P P S - "yea we Learn so much from you Loz" ..... The 'point being' = Some of *US* CAN find contentment in an increasingly MAD, BAD world, without adding to it. | the real lozan | |
16/3/2019 11:03 | From your post """The situation would be discussed and we would consider response.""" """ How are we going to deal with current situation.""" It sounds like a Takeover by A Shareholder who does not have any regulations over Him unlike the Directors that do .. Scancell has to be Hands off the Share Price otherwise it's just pure manipulation with the result that any thing the BOD RNS could not be trusted because it would be written to influence the share price rather than written to make informed judgement of the share price | inanaco | |
16/3/2019 10:49 | Absolutely Inanaco I don’t want to argue and don’t expect a RNS unless news. But you can communicate like podcast/ Pro Actuve I/v just to update market or a RNS R with a general update. When I have been in similar situations yes not at BOD level but equivalent to SCLP BOD within bigger organisations. The situation would be discussed and we would consider response. If the CSO said don’t worry the science is great so just be Katie the hevor she would have been putbinn their place and told that Is not the issyecat hand. How are we going to deal with current situation. As Maggie Thatcher said LordcYoung brought her answers the others bring her problems. We need answers not excuses imo | ivyspivey | |
16/3/2019 10:40 | Ivy et al I think it's fair to say that the RG/LD regime up to last year had rather cleverly (no Brexit pun intended) kept the reward levels (salaries at least) sufficiently restrained to justify a "Give 'em a chance" approach. The last round of adjustments to "get the BOD salaries into line with Bio companies generally" (can't remember the quartile into which they fit as mentioned at the AGM) but fit they do and since that adjustment I don't think it unreasonable to have expected a reason for that increase. Let's face it the "new recruits" joined knowing the approach the original BOD took, but it has been changed with salaries enhanced since last year. The question of Kate Cornish-Bowden's strangely pre AGM departure last year was also IMO rather odd when covered by the following release:- "Scancell Holdings Plc (AIM: SCLP) today announces that Kate Cornish-Bowden will be stepping down as NonExecutive Director as of 31 August 2018 after seven years on the Board of the Company. Dr John Chiplin, Chairman of Scancell, commented: “Kate has made an important contribution in guiding Scancell through its formative years during her time on the Board and in her role as chairman of the Remuneration Committee. We would like to thank her for her hard work and wish her all the best for the future." Did the chairman of the Remuneration Committe disagree with last year's round? We can all make excuses for that event, but why hasn't she been replaced? If she has that will be an oversight on my part, but I don't remember the Company letting the shareholders know .... (back to the issues of keeping Shareholders in the loop). I was rather hoping we'd have been celebrating the Remuneration increases awarded last year by having an RNS that justified the increases (which given the rhetoric from the BOD early in 2018) we might have reasonably expected..... But so far..... Nothing. So although I've generally been hiding behind hopeful Bunny spotting, I will admit to a little unease on that front. Interestingly I remember I'm not alone in this, so maybe we can get a little more openess in that particular context. A good cash providing deal before the end of the current Company year will completely buy my silence on this, but I do find the chain of events last year somewhat strange (as much by lack of information as by lack of fiscally positive events). AIMO ATB | oldnotwise | |
16/3/2019 10:32 | Not going to argue Ivy But exactly what do you want to hear or be put out by RNS ? | inanaco | |
16/3/2019 10:18 | Not SP=SCLP | ivyspivey | |
16/3/2019 10:18 | If DE is watching this board would really appreciate his input into whether in general a small bio Tech is best if served by a group of people who all get along well but may be one a bit cosy. Or better in general to have a more dynamic team with different views and perspectives which yes may cause a bit of disruption in a small team but may help overcome a reluctance to make tough decisions to move a business forward. Appreciate he can’t comment directly on share price or if hevus happy nay give him a private call | ivyspivey | |
16/3/2019 10:11 | At the 2017 AGM when around the same time they made all the good announcements of external validation I made the point to RG that this was great but the proof would be in the pudding. They were taken back a bit at the 2018 AGM with yours and other questioning their response to the decline in share price I was hoping that they would take on board the SH concerns and actually address them like top class BOD would. Unfortunately I feel they judge AGMs as just something to bluff their way through and a necessary evil. In such circumstances like yourself will give it a few months but if they have not upped their commercial game then the next opportunity SH should make it absolutely clear how unhappy they are with BOD performance | ivyspivey | |
16/3/2019 10:05 | Yes I admit I let them off lightly but this lack of action or response from BOD since then is simply very unprofessional and unnaceptable and has crossed a line in my mind. ATB | ivyspivey | |
16/3/2019 09:32 | Ivy, no problem, having not previously attended an AGM I was actually very conservative, I definitely won't be next time. | panama7 | |
16/3/2019 09:21 | Morning Panama If you are attending the next EGM( if it is called) or AGM I will look forward to meeting you properly and the opportunity to listen to how the BOD respond to this current mess and to seriously question their performance especially in the light of the plight of many investors here who you have championed here. | ivyspivey | |
16/3/2019 08:54 | With yesterday's closing price we now have a Market Cap way below the value of all the fundraises and there are Investors who believe our BOD have done a fantastic job. If there is not a Biontech deal or a dramatic uplift in the share price in the next three months there will almost definitely have to be an EGM for to raise sufficient funds. I bet our BOD are really looking forward to that scenario. | panama7 | |
15/3/2019 19:30 | yea we Learn so much from you Loz 1/ grass growing techniques (using the sun) 2/ Ploughing from distant observations 3/ 1664 consumption 4/ size of a window 5/ Funding | inanaco | |
15/3/2019 18:36 | Questions that arise from today - Which is the most disturbing/ alarming/ revealing... is it ??? The obvious LOW opinion, as shown today, inane'n'co has of the ability/intelligence of others/EVERYONE.. to 'Think for themselves' - 'Speak to and for themselves' -'Have their own opinions' OR The 'over-inflated' HIGH opinion - HE has of HIMSELF - as shown AGAIN today, of HIS belief in HIS own { Superior ability/intelligence - above ALL others/ EVERYONE } { On ALL matters } . Some / MANY, might/ would opine = Both amount to the same... and lead to FAILURE | the real lozan |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions